SOMCT02 Huntington’s disease trial recruits 100% of patient target

posted on March 18, 2019
On March 8, 2019, the SOMCT02 clinical trial successfully closed recruitment, marking 100% fulfillment of its targeted number of patients. SOM Biotech is very proud of all the efforts being done by the participating sites, and we are expecting to achieve good results from this clinical trial which will cover a great medical need in…
continue reading →

SOM Biotech closes a financing round of 7M Euros

posted on March 8, 2019
SOM Biotech has just closed a financing round of 7 million euros led by a holding company belonging to a European family with a long tradition in the pharmaceutical sector which will give the opportunity to get a facilitated access to pharma network. Several of the current partners of SOM Biotech have also taken the…
continue reading →

Rare Disease Day 2019

posted on February 28, 2019
Today, February 28th, is Rare Disease Day, and SOM Biotech is one with Eurordis in raising awareness of rare diseases through the #ShowYourRare campaign. SOM Biotech Team Rare Disease Day is the international awareness-raising campaign for rare diseases and is celebrated on the last day of February each year. Since Rare Disease Day started in 2008, thousands of…
continue reading →

Drug Repurposing for Rare Diseases Conference 2019

posted on February 25, 2019
Findacure's Drug Repurposing for Rare Diseases Conference is returning for its sixth consecutive year on February 27, 2019 at the Royal College of Nursing, London. The conference discusses the role that drug repurposing can play in lowering the cost and accelerating the development of rare disease treatments. SOM Biotech is a proud sponsor of the event in…
continue reading →

SOM Biotech renews collaboration with Biotechnology Business Institute

posted on January 28, 2019
With the opening of the Postgraduate programs of Biotechnology Business Institute for the school year 2019, SOM Biotech renews its teaching collaboration with the institute that offers specialized Master's and Postgraduate degrees in International Business Management designed for Life Science degree holders. Biotechnology Business Institute, in educational agreement with the University of Barcelona, is a business school based in…
continue reading →

SOM Biotech at Biotech Showcase/J.P. Morgan 2019

posted on January 14, 2019
Starting the year seizing business opportunities, SOM Biotech attended the Biotech Showcase/J.P. Morgan Conference held on January 7-9, 2019 in San Francisco, California. Biotech Showcase is an investor and networking conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course…
continue reading →